3 pm: Ad hoc-Release Disclosure of an inside information acc. to Article17 MAR of the Regulation (EU) No 596/2014: MEDICLIN publishes forecast for fiscal year 2020

Corona-related precautious free capacities reserved as a precaution in the second quarter of 2020 led to a decline in sales and earnings in the Group - a reliable forecast for the 2020 financial year is not yet possible

Free bed capacity led to a decline in sales and earnings in the first quarter of 2020 – no reliable forecast for the 2020 financial year yet possible

9.59 am: Ad hoc-Release Disclosure of an inside information acc. to Article17 MAR of the Regulation (EU) No 596/2014: MEDICLIN publishes preliminary figures for the first quarter of 2020 and, due to the Corona pandemic, lowers its forecast for 2020

MEDICLIN is satisfied with the 2019 financial year - the outlook for 2020 is fraught with uncertainty

Group sales increased by 4,3 % up to EUR 673.1 mill. – preliminary Group-EBIT amounts to EUR 22.4 mill.

Group sales plus 4 % compared to previous year’s period

Change in the Supervisory Board of MEDICLIN

Significant sales increase in all segements

Ulf Ludwig will resign from the Board of Management